Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Glaukos Corp Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$94.9 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Aug 14, 2018	SELL	$27.62 - $44.51 $2.53 Million - $4.07 Million	-91,500 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$26.05 - $34.5 $2.38 Million - $3.16 Million	91,500 New	91,500 $2.82 Million

Others Institutions Holding GKOS

# of Institutions

345

Shares Held

46.7M

Call Options Held

132K

Put Options Held

188K

Black Rock Inc. New York, NY

8.04M
Shares

$1.29 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

5.87M
Shares

$941 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

2.18M
Shares

$350 Million
0.05% of portfolio
State Street Corp Boston, MA

1.95M
Shares

$313 Million
0.01% of portfolio
Ameriprise Financial Inc Minneapolis, MN

1.64M
Shares

$263 Million
0.06% of portfolio

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.63B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account